Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

F ifty Y ears of R esearch in ARDS.Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value

Open access
Laffey, John G., Matthay, Michael A.·2017·American Journal of Respiratory and Critical Care Medicine

Abstract

On the basis of several preclinical studies, cell-based therapy has emerged as a potential new therapeutic for acute respiratory distress syndrome (ARDS). Of the various cell-based therapy options, mesenchymal stem/stromal cells (MSCs) from bone marrow, adipose tissue, and umbilical cord have the most experimental data to support their potential efficacy for lung injury from both infectious and noninfectious causes. Mechanistically, MSCs exert their beneficial effects by release of paracrine factors, microvesicles, and transfer of mitochondria, all of which have antiinflammatory and pro-resolving effects on injured lung endothelium and alveolar epithelium, including enhancing the resolution of pulmonary edema by up-regulating sodium-dependent alveolar fluid clearance. MSCs also have antimicrobial effects mediated by release of antimicrobial factors and by up-regulating monocyte/macrophage phagocytosis. Phase 2a clinical trials to establish safety in ARDS are in progress, and two phase 1 trials did not report any serious adverse events. Several issues need further study, including: determining the optimal methods for large-scale production, reconstitution of cryopreserved cells for clinical use, defining cell potency assays, and determining the therapeutic potential of conditioned media derived from MSCs. Because ARDS is a heterogeneous syndrome, targeting MSCs to patients with ARDS with a more hyperinflammatory endotype may further enhance their potential for efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201701-0107cp

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 59

  1. Ranieri, 2012, Acute respiratory distress syndrome: the Berlin Definition, JAMA, 307, 2526
  2. Bellani, 2016, Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries, JAMA, 315, 788, 10.1001/jama.2016.0291 · DOI · Paper page
  3. Herridge, 2011, Functional disability 5 years after acute respiratory distress syndrome, N Engl J Med, 364, 1293, 10.1056/NEJMoa1011802 · DOI · Paper page
  4. Tonelli, 2014, Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses, Intensive Care Med, 40, 769, 10.1007/s00134-014-3272-1 · DOI
  5. Calfee, 2014, Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials, Lancet Respir Med, 2, 611, 10.1016/S2213-2600(14)70097-9 · DOI · Paper page
  6. Takahashi, 2016, A decade of transcription factor-mediated reprogramming to pluripotency, Nat Rev Mol Cell Biol, 17, 183, 10.1038/nrm.2016.8 · DOI · Paper page
  7. Kotton, 2012, Next-generation regeneration: the hope and hype of lung stem cell research, Am J Respir Crit Care Med, 185, 1255, 10.1164/rccm.201202-0228PP · DOI
  8. McIntyre, 2014, Expansive generation of functional airway epithelium from human embryonic stem cells, Stem Cells Transl Med, 3, 7, 10.5966/sctm.2013-0119 · DOI
  9. Hao, 2015, Study of bone marrow and embryonic stem cell-derived human mesenchymal stem cells for treatment of Escherichia coli endotoxin-induced acute lung injury in mice, Stem Cells Transl Med, 4, 832, 10.5966/sctm.2015-0006 · DOI
  10. Huang, 2014, Efficient generation of lung and airway epithelial cells from human pluripotent stem cells, Nat Biotechnol, 32, 84, 10.1038/nbt.2754 · DOI · Paper page
  11. La Francesca, 2014, Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study, Transplant Res, 3, 19, 10.1186/2047-1440-3-19 · DOI
  12. Gazdhar, 2014, The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor, Stem Cell Res Ther, 5, 123, 10.1186/scrt513 · DOI
  13. Rafat, 2014, Bone marrow-derived progenitor cells attenuate inflammation in lipopolysaccharide-induced acute respiratory distress syndrome, BMC Res Notes, 7, 613, 10.1186/1756-0500-7-613 · doi:10.1186/1756-0500-7-613
  14. Yin, 2015, Intravenous transplantation of BMP2-transduced endothelial progenitor cells attenuates lipopolysaccharide-induced acute lung injury in rats, Cell Physiol Biochem, 35, 2149, 10.1159/000374020 · doi:10.1159/000374020
  15. Kode, 2009, Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration, Cytotherapy, 11, 377, 10.1080/14653240903080367 · DOI · Paper page
  16. Galipeau, 2016, International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy, 18, 151, 10.1016/j.jcyt.2015.11.008 · DOI · Paper page
  17. Devaney, 2015, Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat, Thorax, 70, 625, 10.1136/thoraxjnl-2015-206813 · DOI · Paper page
  18. Nemeth, 2010, Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma, Proc Natl Acad Sci USA, 107, 5652, 10.1073/pnas.0910720107 · DOI · Paper page
  19. Curley, 2013, Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury, Anesthesiology, 118, 924, 10.1097/ALN.0b013e318287ba08 · DOI
  20. Curley, 2012, Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat, Thorax, 67, 496, 10.1136/thoraxjnl-2011-201059 · DOI · Paper page
  21. Hayes, 2015, Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat, Anesthesiology, 122, 363, 10.1097/ALN.0000000000000545 · DOI
  22. Gore, 2015, Mesenchymal stem cells increase T-regulatory cells and improve healing following trauma and hemorrhagic shock, J Trauma Acute Care Surg, 79, 48, 10.1097/TA.0000000000000681 · doi:10.1097/ta.0000000000000681
  23. Curley, 2015, Stem cells for respiratory failure, Curr Opin Crit Care, 21, 42
  24. Krasnodembskaya, 2012, Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes, Am J Physiol Lung Cell Mol Physiol, 302, L1003, 10.1152/ajplung.00180.2011 · DOI · Paper page
  25. Lee, 2013, Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria, Am J Respir Crit Care Med, 187, 751, 10.1164/rccm.201206-0990OC · DOI · Paper page
  26. Krasnodembskaya, 2010, Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37, Stem Cells, 28, 2229, 10.1002/stem.544 · DOI · Paper page
  27. Ortiz, 2007, Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury, Proc Natl Acad Sci USA, 104, 11002, 10.1073/pnas.0704421104 · DOI · Paper page
  28. Goolaerts, 2014, Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury, Am J Physiol Lung Cell Mol Physiol, 306, L975, 10.1152/ajplung.00242.2013 · DOI
  29. Shen, 2015, Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis, Mol Med Rep, 11, 2831, 10.3892/mmr.2014.3092 · DOI
  30. Fang, 2015, Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4, J Immunol, 195, 875, 10.4049/jimmunol.1500244 · DOI
  31. Monsel, 2015, Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice, Am J Respir Crit Care Med, 192, 324, 10.1164/rccm.201410-1765OC · DOI · Paper page
  32. Zhu, 2014, Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice, Stem Cells, 32, 116, 10.1002/stem.1504 · DOI · Paper page
  33. Gennai, 2015, Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation, Am J Transplant, 15, 2404, 10.1111/ajt.13271 · DOI
  34. Hayes, 2015, Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury, Intensive Care Med Exp, 3, 29, 10.1186/s40635-015-0065-y · DOI
  35. Mitsialis, 2016, Stem cell-based therapies for the newborn lung and brain: possibilities and challenges, Semin Perinatol, 40, 138, 10.1053/j.semperi.2015.12.002 · DOI
  36. Li, 2016, Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice, Stem Cell Res Ther, 7, 159, 10.1186/s13287-016-0395-z · DOI
  37. Chan, 2016, Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo, Proc Natl Acad Sci USA, 113, 3621, 10.1073/pnas.1601911113 · DOI · Paper page
  38. Gotts, 2014, Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy, Am J Physiol Lung Cell Mol Physiol, 307, L395, 10.1152/ajplung.00110.2014 · DOI
  39. Darwish, 2013, Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza, Plos One, 8, e71761, 10.1371/journal.pone.0071761 · DOI
  40. Rojas, 2014, Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep, Stem Cell Res Ther, 5, 42, 10.1186/scrt430 · DOI
  41. Asmussen, 2014, Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia, Thorax, 69, 819, 10.1136/thoraxjnl-2013-204980 · DOI · Paper page
  42. McAuley, 2014, Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation, Am J Physiol Lung Cell Mol Physiol, 306, L809, 10.1152/ajplung.00358.2013 · DOI
  43. Wittwer, 2014, Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation, J Cardiothorac Surg, 9, 151, 10.1186/s13019-014-0151-3 · DOI
  44. Walter, 2014, Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis, Lancet Respir Med, 2, 1016, 10.1016/S2213-2600(14)70217-6 · DOI · Paper page
  45. Wilson, 2015, Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial, Lancet Respir Med, 3, 24, 10.1016/S2213-2600(14)70291-7 · DOI · Paper page
  46. Zheng, 2014, Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study, Respir Res, 15, 39, 10.1186/1465-9921-15-39 · DOI · Paper page
  47. Raicevic, 2011, The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties, Cell Immunol, 270, 207, 10.1016/j.cellimm.2011.05.010 · DOI
  48. Sun, 2015, Mixed serum-deprived and normal adipose-derived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats, Am J Transl Res, 7, 209
  49. Jiang, 2015, Intravenous delivery of adipose-derived mesenchymal stromal cells attenuates acute radiation-induced lung injury in rats, Cytotherapy, 17, 560, 10.1016/j.jcyt.2015.02.011 · DOI
  50. Mao, 2015, Adipose tissue-derived mesenchymal stem cells attenuate pulmonary infection caused by pseudomonas aeruginosa via inhibiting overproduction of prostaglandin E2, Stem Cells, 33, 2331, 10.1002/stem.1996 · DOI
  51. Nazarov, 2012, Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential, Stem Cells Transl Med, 1, 359, 10.5966/sctm.2011-0021 · DOI
  52. Curley, 2017, Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli-induced acute respiratory distress syndrome, Crit Care Med, 45, e202, 10.1097/CCM.0000000000002073 · DOI
  53. Sung, 2013, Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats, Stem Cell Res Ther, 4, 155, 10.1186/scrt385 · DOI
  54. Bustos, 2014, Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response, Am J Respir Crit Care Med, 189, 787, 10.1164/rccm.201306-1043OC · DOI · Paper page
  55. Lee, 2014, TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo, Proc Natl Acad Sci USA, 111, 16766, 10.1073/pnas.1416121111 · DOI · Paper page
  56. Ruiz-Delgado, 2009, Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature, Acta Haematol, 122, 1, 10.1159/000227267 · doi:10.1159/000227267
  57. Lalu, 2012, Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials, Plos One, 7, e47559, 10.1371/journal.pone.0047559 · DOI · Paper page
  58. Famous, 2017, Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy, Am J Respir Crit Care Med, 195, 331, 10.1164/rccm.201603-0645OC · DOI · Paper page
  59. Sjoding, 2016, Acute respiratory distress syndrome measurement error, Ann Am Thorac Soc, 13, 1123, 10.1513/AnnalsATS.201601-072OC · doi:10.1513/annalsats.201601-072oc

Cited by

See all 226

Metadata

Authors
Laffey, J. G., & Matthay, M. A.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2017-08-01
Volume
196
Issue
3
Pages
266-273
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2596348429
Cited by
226
References
7
FWCI
12.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: F ifty Y ears of R esearch in ARDS.Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. https://app.cochat.ai/papers/10.1164/rccm.201701-0107cp
The paper
Laffey, J. G., & Matthay, M. A. (2017). F ifty Y ears of R esearch in ARDS.Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201701-0107cp

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.